ArticleMolecular medicine (Cambridge, Mass.)2026
Correction: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Mohammed Salah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.